Genpact (NYSE:G – Get Free Report) updated its first quarter 2025 earnings guidance on Thursday. The company provided earnings per share guidance of 0.790-0.800 for the period, compared to the consensus earnings per share estimate of 0.780. The company issued revenue guidance of $1.2 billion-$1.2 billion, compared to the consensus revenue estimate of $1.2 billion. Genpact also updated its FY 2025 guidance to 3.520-3.590 EPS.
Genpact Trading Down 0.1 %
NYSE G traded down $0.04 on Thursday, hitting $49.38. The company’s stock had a trading volume of 1,256,998 shares, compared to its average volume of 1,325,743. The company has a quick ratio of 1.85, a current ratio of 1.85 and a debt-to-equity ratio of 0.50. Genpact has a 1-year low of $30.23 and a 1-year high of $49.68. The firm has a market cap of $8.71 billion, a PE ratio of 13.56, a PEG ratio of 1.61 and a beta of 1.20. The company’s 50-day moving average is $44.86 and its 200 day moving average is $41.09.
Genpact (NYSE:G – Get Free Report) last issued its quarterly earnings results on Thursday, November 7th. The business services provider reported $0.75 earnings per share for the quarter, topping analysts’ consensus estimates of $0.71 by $0.04. Genpact had a return on equity of 21.85% and a net margin of 14.22%. The firm had revenue of $1.21 billion during the quarter, compared to the consensus estimate of $1.19 billion. During the same period last year, the business posted $0.67 EPS. As a group, analysts predict that Genpact will post 2.94 earnings per share for the current fiscal year.
Wall Street Analysts Forecast Growth
Get Our Latest Research Report on Genpact
Insider Buying and Selling
In other Genpact news, CEO Balkrishan Kalra sold 9,000 shares of the business’s stock in a transaction that occurred on Monday, November 25th. The stock was sold at an average price of $46.40, for a total value of $417,600.00. Following the completion of the sale, the chief executive officer now owns 267,404 shares in the company, valued at approximately $12,407,545.60. The trade was a 3.26 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, SVP Piyush Mehta sold 12,000 shares of the firm’s stock in a transaction that occurred on Friday, January 10th. The stock was sold at an average price of $42.83, for a total transaction of $513,960.00. Following the completion of the transaction, the senior vice president now owns 151,182 shares in the company, valued at $6,475,125.06. This represents a 7.35 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 35,058 shares of company stock worth $1,558,675. Corporate insiders own 2.80% of the company’s stock.
About Genpact
Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.
Recommended Stories
- Five stocks we like better than Genpact
- What Are Growth Stocks and Investing in Them
- Price Plunge in Roblox Presents Opportunity for Robust Gains
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- Billions in Buybacks: 4 Stocks Rewarding Shareholders Now
- How Can Investors Benefit From After-Hours Trading
- 3 Steel Stocks to Gain Strength as Tariffs Reshape the Market
Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.